These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
65 related articles for article (PubMed ID: 2067414)
1. Pharmacokinetics of cefuroxime and ciprofloxacin in gastric mucosa: comparison to in vitro inhibitory concentrations against Helicobacter pylori. Westblom TU; Duriex DE Microbiologica; 1991 Jan; 14(1):37-43. PubMed ID: 2067414 [TBL] [Abstract][Full Text] [Related]
2. Guinea pig model for antibiotic transport across gastric mucosa: inhibitory tissue concentrations of clindamycin against Helicobacter pylori (Campylobacter pylori) following two separate dose regimens. Westblom TU; Duriex DE; Madan E; Belshe RB Antimicrob Agents Chemother; 1990 Jan; 34(1):25-8. PubMed ID: 2327758 [TBL] [Abstract][Full Text] [Related]
3. Single-dose intrapulmonary pharmacokinetics of azithromycin, clarithromycin, ciprofloxacin, and cefuroxime in volunteer subjects. Conte JE; Golden J; Duncan S; McKenna E; Lin E; Zurlinden E Antimicrob Agents Chemother; 1996 Jul; 40(7):1617-22. PubMed ID: 8807050 [TBL] [Abstract][Full Text] [Related]
4. Enhancement of antibiotic concentrations in gastric mucosa by H2-receptor antagonist. Implications for treatment of Helicobacter pylori infections. Westblom TU; Duriex DE Dig Dis Sci; 1991 Jan; 36(1):25-8. PubMed ID: 1985000 [TBL] [Abstract][Full Text] [Related]
5. Serum and tissue cage fluid concentrations of ciprofloxacin after oral administration of the drug to healthy dogs. Walker RD; Stein GE; Hauptman JG; MacDonald KH; Budsberg SC; Rosser EJ Am J Vet Res; 1990 Jun; 51(6):896-900. PubMed ID: 2195927 [TBL] [Abstract][Full Text] [Related]
7. Prevalence of Helicobacter pylori in gastrointestinal disorders and concentrations of ciprofloxacin in serum and gastric mucosa. Krausse R; Lorentzen T; Erttmann M; Ullmann U Zentralbl Bakteriol; 1993 Sep; 280(1-2):286-96. PubMed ID: 8280954 [TBL] [Abstract][Full Text] [Related]
8. Lung tissue concentrations of ciprofloxacin following intravenous administration in patients. Forst H; Ruckdeschel G; Unertl K; Dieterich HJ; Ehret W; Sunder-Plassmann L Arzneimittelforschung; 1989 May; 39(5):618-9. PubMed ID: 2757681 [TBL] [Abstract][Full Text] [Related]
9. Disposition kinetics of ciprofloxacin in lactating goats. el-Banna HA; Abo el-Sooud K Dtsch Tierarztl Wochenschr; 1998 Jan; 105(1):35-8. PubMed ID: 9499632 [TBL] [Abstract][Full Text] [Related]
10. Effect of omeprazole on gastric mucosa and serum levels of amoxicillin in patients with non-ulcer dyspepsia. Wittayalertpanya S; Wannachai N; Thongnopnua P; Mahachai V J Med Assoc Thai; 2000 Jun; 83(6):611-8. PubMed ID: 10932486 [TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetic variables and tissue residues of enrofloxacin and ciprofloxacin in healthy pigs. Anadón A; Martínez-Larrañaga MR; Díaz MJ; Fernández-Cruz ML; Martínez MA; Frejo MT; Martínez M; Iturbe J; Tafur M Am J Vet Res; 1999 Nov; 60(11):1377-82. PubMed ID: 10566812 [TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics and intramuscular bioavailability of cefuroxime sodium in goats. ABO EL-SOOUD K; El-Banna HA; Hanafy MS; Goudah A Res Vet Sci; 2000 Dec; 69(3):219-24. PubMed ID: 11124092 [TBL] [Abstract][Full Text] [Related]
14. [Pulmonary and bronchial kinetics of cefuroxime after a single 500 mg intramuscular injection]. Le Gros V; Farinotti R; Brion N; Regnard JF; Azorin J; Parrot AM; Chiche D Pathol Biol (Paris); 1992 May; 40(5):545-50. PubMed ID: 1495842 [TBL] [Abstract][Full Text] [Related]
15. Polyamine profile in human gastric mucosa infected by Helicobacter pylori. Linsalata M; Russo F; Notarnicola M; Berloco P; Di Leo A Ital J Gastroenterol Hepatol; 1998 Oct; 30(5):484-9. PubMed ID: 9836101 [TBL] [Abstract][Full Text] [Related]
16. Effect of the flavonoid quercetin on inflammation and lipid peroxidation induced by Helicobacter pylori in gastric mucosa of guinea pig. González-Segovia R; Quintanar JL; Salinas E; Ceballos-Salazar R; Aviles-Jiménez F; Torres-López J J Gastroenterol; 2008; 43(6):441-7. PubMed ID: 18600388 [TBL] [Abstract][Full Text] [Related]
17. Minimum inhibitory concentration of various single agents and the effect of their combinations against Helicobacter pylori, as estimated by a fast and simple in vitro assay method. Bamba H; Kondo Y; Wong RM; Sekine S; Matsuzaki F Am J Gastroenterol; 1997 Apr; 92(4):659-62. PubMed ID: 9128318 [TBL] [Abstract][Full Text] [Related]
18. Levels of malondialdehyde-deoxyguanosine in the gastric mucosa: relationship with lipid peroxidation, ascorbic acid, and Helicobacter pylori. Everett SM; Singh R; Leuratti C; White KL; Neville P; Greenwood D; Marnett LJ; Schorah CJ; Forman D; Shuker D; Axon AT Cancer Epidemiol Biomarkers Prev; 2001 Apr; 10(4):369-76. PubMed ID: 11319178 [TBL] [Abstract][Full Text] [Related]
19. Vitamin C inhibits the growth of a bacterial risk factor for gastric carcinoma: Helicobacter pylori. Zhang HM; Wakisaka N; Maeda O; Yamamoto T Cancer; 1997 Nov; 80(10):1897-903. PubMed ID: 9366290 [TBL] [Abstract][Full Text] [Related]
20. Serum pepsinogen concentration as a marker of Helicobacter pyloriinfection and the histologic grade of gastritis; evaluation of gastric mucosa by serum pepsinogen levels. Kiyohira K; Yoshihara M; Ito M; Haruma K; Tanaka S; Chayama K J Gastroenterol; 2003; 38(4):332-8. PubMed ID: 12743772 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]